MIT induced cleavage of caspase 3, a process remarkably weakened by stromal EREG but sustained upon elimination of EREG from PSC27 cells (Supplementary Fig. 5f), suggesting EREG drives cancer resistance largely via a caspase-counteracting mechanism. The gene discussed is CASP3; the disease is cancer.